Eli Lilly and Company (NYSE:LLY) announced a $30 million commitment over five years to fight the rising burden of non-communicable diseases in developing nations. Lilly is launching The Lilly NCD Partnership, which combines the company's unique resources with the expertise of leading global health organizations, to identify new models of patient care that increase treatment access and improve outcomes for underserved people. The partnership will initially focus on diabetes a core business area in which Lilly has deep expertise.

Read more at: http://crwewallstreet.com/?p=21313